Risk of severe COVID-19 outcomes after autumn 2022 COVID-19 booster vaccinations: a pooled analysis of national prospective cohort studies involving 7.4 million adults in England, Northern Ireland, Scotland and WalesResearch in context

Summary: Background: UK COVID-19 vaccination policy has evolved to offering COVID-19 booster doses to individuals at increased risk of severe Illness from COVID-19. Building on our analyses of vaccine effectiveness of first, second and initial booster doses, we aimed to identify individuals at incr...

Cijeli opis

Bibliografski detalji

Glavni autori:	Stuart Bedston, Fatima Almaghrabi, Lynsey Patterson, Utkarsh Agrawal, Lana Woolford, Sneha N. Anand, Mark Joy, Anna Crawford, Rosalind Goudie, Rachel Byford, Hoda Abbasizanjani, Deb Smith, Lynn Laidlaw, Ashley Akbari, Christopher Sullivan, Declan T. Bradley, Ronan A. Lyons, Simon de Lusignan, F.D. Richard Hobbs, Chris Robertson, Sir Aziz Sheikh, Ting Shi
Format:	Artigo
Jezik:	Inglês
Izdano:	Elsevier 2024-02-01
Serija:	The Lancet Regional Health. Europe
Teme:	COVID-19 Vaccine Hospital admission Vaccine breakthrough Booster dose
Online pristup:	http://www.sciencedirect.com/science/article/pii/S2666776223002351
Oznake:	Dodaj oznaku Bez oznaka, Budi prvi tko označuje ovaj zapis!